More on IKT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.6 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Inhibikase Therapeutics (NQ:IKT)
Delayed: 2.11 +0.10 (4.98%)
Prev. Close $2.01  
Open$1.96 
52 Wk High$ 
52 Wk Low$ 
Day High$2.15 
Day Low$1.94 
P/E N/A  
EPS$ 
Volume1,735,638 


Jul 17, 2026 05:55 PM Form 3 Inhibikase Therapeutics, For: Jul 10 Filed by: Kolchinsky Peter
Jul 17, 2026 05:53 PM Form SCHEDULE 13G Inhibikase Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 14, 2026 08:11 AM Form 8-K Inhibikase Therapeutics, For: Jul 14
Jul 14, 2026 08:00 AM Inhibikase sells $50M in shares to RA Capital via ATM facility
Jul 14, 2026 08:00 AM Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility
Jul 2, 2026 04:01 PM Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 30, 2026 04:05 PM Form 4 Inhibikase Therapeutics, For: Jun 26 Filed by: BERMAN DENNIS N
Jun 30, 2026 04:05 PM Form 4 Inhibikase Therapeutics, For: Jun 26 Filed by: Aurentz Vincent
Jun 30, 2026 04:05 PM Form 4 Inhibikase Therapeutics, For: Jun 26 Filed by: Munshi Amit
Jun 30, 2026 04:05 PM Form 4 Inhibikase Therapeutics, For: Jun 26 Filed by: Bellini Roberto
View All Articles

Entities mentioned with IKT

View All Entities